Education
About Us
Working with TipRanks
Follow Us
Guardant Health (GH)
NASDAQ:GH
Total Valuation
Guardant Health has a market cap or net worth of $12.14B. The enterprise value is $13.27B.
Market Cap$12.14B
Enterprise Value$13.27B
Share Statistics
Guardant Health has 131,170,440 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding131,170,440
Owned by Insiders3.43%
Owned by Institutions16.14%
Financial Efficiency
Guardant Health’s return on equity (ROE) is 4.19 and return on invested capital (ROIC) is -25.42%.
Return on Equity (ROE)4.19
Return on Assets (ROA)-0.21
Return on Invested Capital (ROIC)-25.42%
Return on Capital Employed (ROCE)-0.26
Revenue Per Employee491.26K
Profits Per Employee-208.24K
Employee Count1,999
Asset Turnover0.49
Inventory Turnover4.06
Valuation Ratios
The current PE Ratio of Guardant Health is ―. Guardant Health’s PEG ratio is 4.56.
PE Ratio―
PS Ratio13.04
PB Ratio-128.95
Price to Fair Value-128.95
Price to FCF-54.94
Price to Operating Cash Flow-68.03
PEG Ratio4.56
Income Statement
In the last 12 months, Guardant Health had revenue of 982.02M and earned -416.28M in profits. Earnings per share was -3.32.
Revenue982.02M
Gross Profit633.01M
Operating Income-436.30M
Pretax Income-417.54M
Net Income-416.28M
EBITDA-373.91M
Earnings Per Share (EPS)-3.32
Cash Flow
In the last 12 months, operating cash flow was -172.47M and capital expenditures -48.31M, giving a free cash flow of -220.78M billion.
Operating Cash Flow-172.47M
Free Cash Flow-220.78M
Free Cash Flow per Share-1.68
Dividends & Yields
Guardant Health pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.51
52-Week Price Change131.94%
50-Day Moving Average105.27
200-Day Moving Average75.42
Relative Strength Index (RSI)35.89
Average Volume (3m)1.99M
Important Dates
Guardant Health upcoming earnings date is Apr 30, 2026, After Close (Confirmed).
Last Earnings DateFeb 19, 2026
Next Earnings DateApr 30, 2026
Ex-Dividend Date―
Financial Position
Guardant Health as a current ratio of 4.84, with Debt / Equity ratio of -1694.20%
Current Ratio4.84
Quick Ratio4.56
Debt to Market Cap0.13
Net Debt to EBITDA-3.49
Interest Coverage Ratio-111.96
Taxes
In the past 12 months, Guardant Health has paid -1.26M in taxes.
Income Tax-1.26M
Effective Tax Rate<0.01
Enterprise Valuation
Guardant Health EV to EBITDA ratio is -37.74, with an EV/FCF ratio of -60.54.
EV to Sales14.37
EV to EBITDA-37.74
EV to Free Cash Flow-60.54
EV to Operating Cash Flow-76.37
Balance Sheet
Guardant Health has $1.20B in cash and marketable securities with $1.68B in debt, giving a net cash position of -$480.87M billion.
Cash & Marketable Securities$1.20B
Total Debt$1.68B
Net Cash-$480.87M
Net Cash Per Share-$3.67
Tangible Book Value Per Share-$1.62
Margins
Gross margin is 64.46%, with operating margin of -44.43%, and net profit margin of -42.39%.
Gross Margin64.46%
Operating Margin-44.43%
Pretax Margin-42.52%
Net Profit Margin-42.39%
EBITDA Margin-38.08%
EBIT Margin-42.12%
Analyst Forecast
The average price target for Guardant Health is $132.58, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$132.58
Price Target Upside43.21% Upside
Analyst ConsensusStrong Buy
Analyst Count21
Revenue Growth Forecast30.38%
EPS Growth Forecast24.17%